300 related articles for article (PubMed ID: 1465835)
1. Negative crossmatch on current sera and good HLA matching are the main requirements for renal transplantation in highly sensitized patients.
Cristol JP; Mourad G; Argiles A; Seignalet J; Iborra F; Ramounau-Pigot A; Chong G; Mion C
Transplant Proc; 1992 Dec; 24(6):2470-1. PubMed ID: 1465835
[No Abstract] [Full Text] [Related]
2. Repeated mismatches may not impair survival of renal regrafts in recipients with 0% to 50% panel reactive antibodies.
Mjörnstedt L; Konar J; Skarp I; Olausson M; Sandberg L; Tufvesson G
Transplant Proc; 1992 Dec; 24(6):2469. PubMed ID: 1465834
[No Abstract] [Full Text] [Related]
3. Repeated HLA mismatch in multiple kidney transplantation: preliminary results of 146 retransplantations in the cyclosporine era.
Gnant MF; Sautner T; Rosenmayr A; Muehlbacher F
Transplant Proc; 1992 Dec; 24(6):2466-8. PubMed ID: 1465833
[No Abstract] [Full Text] [Related]
4. Influence of HLA antigens of renal transplant recipients on graft survival.
Alamartine E; Berthoux F; Acquart S; Lepetit JC
Transplant Proc; 1992 Dec; 24(6):2461-2. PubMed ID: 1465831
[No Abstract] [Full Text] [Related]
5. Disappearance of anti-HLA antibodies in highly sensitized patients treated with erythropoietin.
Mourad G; Cristol JP; Chong G; Lorho R; Argiles A; Seignalet J; Mion C
Transplant Proc; 1992 Dec; 24(6):2512-3. PubMed ID: 1465849
[No Abstract] [Full Text] [Related]
6. Influence of HLA matching on the outcome of kidney transplants in a single center analysis.
Schanz D; Blümke M; Keller E; Tanzi-Fetta RF; Kirste G
Transplant Proc; 1992 Dec; 24(6):2455. PubMed ID: 1465828
[No Abstract] [Full Text] [Related]
7. Cadaveric kidney transplantation in patients with lymphocytotoxic autoantibodies.
Emonds MP; Dendievel J; Roels L; Waer M; Vanrenterghem Y; Vermylen C
Transplant Proc; 1992 Dec; 24(6):2502-3. PubMed ID: 1465845
[No Abstract] [Full Text] [Related]
8. Enhanced renal graft survival in HLA-A mismatched transplants.
Bućin D; Ekberg H; Lindholm A; Persson H; Tufvesson G; Albrechtsen D
Transplant Proc; 1992 Dec; 24(6):2473-4. PubMed ID: 1465837
[No Abstract] [Full Text] [Related]
9. Six-year experience with a triple drug protocol in renal transplantation: analysis of risk factors.
Pallardó LM; Sánchez P; Sánchez J; García J; Orero E; Beneyto I; Cruz JM
Transplant Proc; 1992 Dec; 24(6):2714-5. PubMed ID: 1465911
[No Abstract] [Full Text] [Related]
10. Quality of serological donor HLA typing: analysis of graft survival by HLA in renal transplantation recipients treated with cyclosporine.
Thorogood J; Schreuder GM; Persijn GG; van Rood JJ
Transplant Proc; 1992 Dec; 24(6):2485-7. PubMed ID: 1465839
[No Abstract] [Full Text] [Related]
11. Relevance of positive crossmatches in renal transplantation.
Horsburgh T; Mistry N; Weston S; Morgan J; Donnelly PK; Veitch PS; Bell PR
Transplant Proc; 1992 Dec; 24(6):2508-9. PubMed ID: 1465848
[No Abstract] [Full Text] [Related]
12. The graft survival curve: ideology and rhetoric.
Guttmann RD
Transplant Proc; 1992 Dec; 24(6):2407-10. PubMed ID: 1465810
[No Abstract] [Full Text] [Related]
13. Autoreactive IgM non-HLA antibodies are not entirely clinically irrelevant. The Manchester UK Kidney Transplant Team.
Martin S; Dyer PA; Scott PD
Transplant Proc; 1992 Dec; 24(6):2504. PubMed ID: 1465846
[No Abstract] [Full Text] [Related]
14. Patterns of "hidden" humoral allosensitization to HLA-A2 revealed by a simple modification of the standard lymphocytotoxic test.
Bohinjec M; Vidan B
Transplant Proc; 1992 Dec; 24(6):2497-501. PubMed ID: 1465844
[No Abstract] [Full Text] [Related]
15. Single center experience with the CTS-HIT allocation system for highly immunized patients. The Leuven Collaborative Group for Transplantation.
Roels L; Vanrenterghem Y; Waer M; Dendievel J; Emonds MP; Christiaens R; Gruwez J; Michielsen P
Transplant Proc; 1992 Dec; 24(6):2492-3. PubMed ID: 1465841
[No Abstract] [Full Text] [Related]
16. Effect of anti-HLA and anti-idiotypic antibodies on the long-term survival of heart and kidney allografts.
Reed E; Cohen DJ; Barr ML; Ho E; Marboe CC; Rose EA; Hardy M; Suciu-Foca N
Transplant Proc; 1992 Dec; 24(6):2494-5. PubMed ID: 1465842
[TBL] [Abstract][Full Text] [Related]
17. Reliability of HLA typing on peripheral blood lymphocytes in cadaveric organ donors and the impact of blank donor antigens on kidney graft survival.
Offermann G; Bünte S; Angelides U; Geidner U; Kirschbaum B; Müller E; Wendt N
Transplant Proc; 1992 Dec; 24(6):2488-9. PubMed ID: 1361261
[No Abstract] [Full Text] [Related]
18. HLA typing on peripheral blood lymphocytes from cadaveric donors to reduce cold ischemia.
Muñoz C; Franco A; Prados MC; de la Sen ML; Perdiguero M; Olivares J
Transplant Proc; 1992 Dec; 24(6):2490-1. PubMed ID: 1465840
[No Abstract] [Full Text] [Related]
19. Role of anti-idiotypic antibodies in sensitized patients awaiting renal transplantation.
Ramounau-Pigot A; Mourad G; Cristol JP; Argiles A; Seignalet J
Transplant Proc; 1992 Dec; 24(6):2496. PubMed ID: 1465843
[No Abstract] [Full Text] [Related]
20. Influence of recipient's HLA type on the outcome of renal transplantation.
Forsberg B; Ekberg H; Johnson U
Transplant Proc; 1992 Dec; 24(6):2463-5. PubMed ID: 1465832
[No Abstract] [Full Text] [Related]
[Next] [New Search]
